Protalix BioTherapeutics to Present at the UBS Global Life Sciences Conference
CARMIEL, Israel, Sept. 13 /PRNewswire-FirstCall/ -- Protalix BioTherapeutics, Inc. (NYSE-AMEX: PLX, TASE: PLX), announced today that Dr. David Aviezer, Protalix's president and CEO, will present at the UBS Global Life Sciences Conference on September 20, 2010 at 10:30 AM ET. The conference is being held September 20 - 22, 2010 at the Grand Hyatt Hotel in New York City. An audio webcast of the ...
Read more on redO
No comments:
Post a Comment